We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


CytoGenix Announces Collaboration with USDA Agricultural Research Service

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

CytoGenix, Inc. has announced that it has entered into a formal Cooperative Research and Development Agreement (CRADA) with the USDA Agricultural Research Service

CytoGenix scientists will work with a team of USDA scientists led by Dr. Steven Olsen to develop synDNA™ vaccines against existing and emerging strains of the bacteria that causes brucellosis.

Dr. Olsen, Director of Vaccine Research for the Agricultural Research Service, USDA commented, "There remain reservoirs of brucella in wildlife within Yellowstone Park, and the potential for brucellosis infection is a serious threat to cattle ranchers in the region."

"For this reason, ARS has been conducting research to develop DNA vaccines for brucella infections for several years."

Dr. Malcolm Skolnick, CytoGenix Chief Executive Officer, commented, "We are pleased to be working with Dr. Olsen and his team of scientists at USDA."

"ARS is a leader within the Federal government in the transferal and marketing of new technologies developed from its research laboratories."

"This CRADA is another example of our commitment to exploring the utility of synDNA™ technology in cooperation with governmental agencies."